Order Article Reprints

Gomez-Gaitan EA, Garcia-Ortega YE, Saldaña-Cruz AM, Contreras-Haro B, Gamez-Nava JI, Perez-Guerrero EE, Nava-Valdivia CA, Gallardo-Moya S, Martinez-Hernandez A, Gonzalez Lopez L, et al. Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study. International Journal of Molecular Sciences. 2023; 24(19):14594. https://doi.org/10.3390/ijms241914594

Gomez-Gaitan, Esteban Alejandro, Yessica Eleanet Garcia-Ortega, Ana Miriam Saldaña-Cruz, Betsabe Contreras-Haro, Jorge Ivan Gamez-Nava, Emilio Edsaul Perez-Guerrero, Cesar Arturo Nava-Valdivia, Sergio Gallardo-Moya, Alejandra Martinez-Hernandez, Laura Gonzalez Lopez, and et al. 2023. "Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study" International Journal of Molecular Sciences 24, no. 19: 14594. https://doi.org/10.3390/ijms241914594

Gomez-Gaitan, E. A., Garcia-Ortega, Y. E., Saldaña-Cruz, A. M., Contreras-Haro, B., Gamez-Nava, J. I., Perez-Guerrero, E. E., Nava-Valdivia, C. A., Gallardo-Moya, S., Martinez-Hernandez, A., Gonzalez Lopez, L., Rios-Gonzalez, B. E., Marquez-Pedroza, J., Mendez-del Villar, M., Esparza-Guerrero, Y., Villagomez-Vega, A., & Macias Islas, M. A. (2023). Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study. International Journal of Molecular Sciences, 24(19), 14594. https://doi.org/10.3390/ijms241914594